GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,320,000 | +7274.0% | 283,700 | +3075.2% | 0.03% | – |
| Q4 2021 | $262,000 | -88.0% | 8,935 | -89.5% | 0.00% | -100.0% |
| Q3 2021 | $2,175,000 | +22.5% | 85,361 | +68.4% | 0.00% | +50.0% |
| Q2 2021 | $1,775,000 | -44.2% | 50,680 | +0.6% | 0.00% | -33.3% |
| Q2 2020 | $3,182,000 | +668.6% | 50,400 | +522.2% | 0.00% | – |
| Q1 2020 | $414,000 | -98.9% | 8,100 | -99.0% | 0.00% | -100.0% |
| Q2 2018 | $39,390,000 | +33.3% | 829,500 | +35.6% | 0.02% | -31.2% |
| Q1 2018 | $29,550,000 | +410.5% | 611,800 | +228.2% | 0.03% | +357.1% |
| Q3 2017 | $5,788,000 | +148.1% | 186,400 | +84.2% | 0.01% | +75.0% |
| Q3 2016 | $2,333,000 | – | 101,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |